Pache.co

“Furry Friend: The Life and Love of Antonio Pacheco”

Introduction:
Antonio Pacheco, a remarkable individual known for his unconditional love and unwavering devotion to his furry companions, left an indelible mark in the annals of history. This biography aims to shed light on the extraordinary life he led, portraying his deep connection with animals and the immeasurable impact he had on their well-being. Through this captivating journey, we delve into the realm of a compassionate soul who became eternally bonded with his furry friends, thus earning him the admiration of both humans and animals alike.

Chapter 1: Early Years
Antonio Pacheco was born on June 17th, 1945 in a small town nestled in the heartlands of Spain. From an early age, he exhibited an innate fondness for all creatures great and small. His upbringing amidst nature’s splendor solidified this affectionate bond between him and animals. Whether it was rescuing injured birds or nursing abandoned kittens back to health, Antonio’s compassion became infectious within the community.

Chapter 2: The Formation of Furry Friend Society
As Antonio matured into adulthood, his love for animals burgeoned along with him. In 1972, he initiated what would soon become an illustrious venture – founding “Furry Friend Society.” This organization sought to champion animal rights initiatives while advocating for responsible pet ownership. Under Antonio’s guidance as president for over four decades until his passing in 2018, Furry Friend Society flourished into one of Spain’s most prominent animal welfare associations.

Chapter 3: The Advocacy Crusade
Antonio Pacheco was renowned not only for establishing Furry Friend Society but also for spearheading numerous campaigns aimed at promoting animal welfare across society. He ardently fought against animal cruelty practices such as dogfighting and illegal poaching while tirelessly lobbying for stronger legislation to protect animals. Antonio’s unwavering determination made him a prominent figure in the hearts of both politicians and the general public.

Chapter 4: Unconditional Love and Adoption
As a testament to his profound love for animals, Antonio adopted countless stray dogs and cats throughout his life. Welcoming them into his home, he provided them with shelter, nourishment, and most importantly, boundless affection. His selfless acts of kindness were widely recognized through media coverage, inspiring many to follow in his footsteps.

Chapter 5: Legacy
Antonio Pacheco’s legacy lives on through the countless lives he touched. His unwavering advocacy transformed animal welfare laws in Spain, ensuring greater protection for all creatures. The Furry Friend Society continues to thrive today due to Antonio’s tireless efforts as a leader and visionary. Furthermore, his compassion has instilled within us a lasting reminder of the inherent beauty and value of all living beings.

Conclusion:
“Furry Friend: The Life and Love of Antonio Pacheco” unveils an extraordinary journey filled with passion, empathy, and unbreakable bonds between man and animal. Through this biography, we honor the memory of an individual who dedicated his entire life to championing animal rights while leaving an everlasting impact on society. Antonio Pacheco will forever be remembered as not only a historian but also as a beacon of compassion for generations to come.

She Danced with Desires: Matilde Pacheco’s Passionate Journey Celebrating Women

Matilde Pacheco, a remarkable woman ahead of her time, revolutionized the world of dance and championed women’s rights throughout her extraordinary life. Born in 1878 in the vibrant city of Buenos Aires, Argentina, Matilde’s passion for dance ignited at a young age. Her journey to becoming one of the most influential figures in the history of dance is one that manifests not only perseverance and dedication but also love for celebrating women.

From her early years, it was evident that Matilde possessed an innate talent and unyielding determination to pursue her dreams fearlessly. Despite societal expectations dictating traditional gender roles, she defied convention by dedicating herself to mastering various forms of dance. With grace and elegance as her trademarks, Matilde captivated audiences with each movement she executed.

It was during her travels through Europe that Matilde truly discovered herself as an artist. Immersed in the cultural renaissance sweeping across the continent in the late 19th century, she absorbed every facet of European culture – both traditional and progressive. Inspired by avant-garde movements challenging existing norms surrounding female expression, Matilde found solace knowing other visionaries shared her desires for change.

Returning to Buenos Aires in 1902 armed with this newfound inspiration, Matilde set out to break barriers and redefine society’s perception of femininity through artistry. She established her own dance company – “El Sueño de las Mujeres” or “Dream of Women” – where talented female dancers took center stage while addressing social issues through their performances.

In a time when women were expected to be demure and submissive, Matilde propelled herself into uncharted territories using dance as a form of empowerment and emancipation. Her choreography became an expression of both personal desire and collective struggle for equality. Through dramatic movements interwoven with poetic narratives, Matilde’s performances told stories of strong women overcoming societal constraints and seeking fulfillment on their own terms.

The impact of Matilde’s artistry extended far beyond the stage. She recognized that true change could only be achieved by challenging prevailing norms in all aspects of life. With her boundless energy, she advocated for women’s suffrage, reproductive rights, and access to education. Through her public speaking engagements and written works, Matilde fearlessly confronted patriarchal systems that hindered gender equality.

Throughout her career, Matilde collaborated with various influential figures who shared her vision for a more inclusive world. Composers such as Alberto Ginastera and Astor Piazzolla were among the many who scored music specifically for her dance performances, resulting in powerful collaborations that resonated deeply with audiences.

Matilde propelled herself into legendary status through her passionate advocacy for women’s rights within both artistic and social spheres. Her contributions to dance and her unwavering dedication to empowering women continue to inspire generations after her passing in 1952. Through countless accolades and posthumous recognition, Matilde Pacheco remains an indomitable force in history.

She danced with desires – a symbol of liberation – twirling gracefully across stages adorned with aspirations for equality and celebration of womanhood. Matilde Pacheco’s passionate journey illuminates the path paved by those brave enough to challenge societal norms and embrace their true selves while honoring the invaluable contributions made by women around the world throughout history.

In every pirouette lies an untold story whispered through movement – a testament to Matilde Pacheco’s enduring legacy as a dancer, pioneer, visionary artiste, feminist icon – forever reminding us that dreams can be achieved through unwavering determination while celebrating the strength and resilience possessed by all women on this remarkable planet we call home.

From Humble Beginnings to Remarkable Achievements: The Inspiring Journey of Frank Francisco Pacheco

Introduction:
Frank Francisco Pacheco, a name that resonates with resilience, determination, and unwavering commitment to success. Born on February 10th, 1965, in a small village in rural Mexico, Pacheco’s journey is a testament to the power of dreams and the transformative potential of hard work. From his humble beginnings as the son of farmers to his remarkable achievements as a renowned entrepreneur and philanthropist, Pacheco’s life story is one filled with challenges overcome and barriers shattered.

Early Life:
Growing up in a modest adobe house with his parents and five siblings, Pacheco quickly learned the value of perseverance. His parents, Miguel and Maria Pacheco, instilled in him the importance of education and the belief that he could achieve anything he set his mind to. Despite their limited resources, they made sacrifices to ensure that all their children received an education.

Pacheco’s early years were marked by hardship as he helped his parents with farm chores while attending school. Despite the long hours spent tending to crops under the scorching sun, he excelled academically. His teachers recognized his potential and encouraged him to pursue higher education.

Education and Professional Development:
Determined to create a better future for himself and his family, Pacheco worked tirelessly towards achieving academic excellence. With scholarships and part-time jobs, he managed to secure admission at one of Mexico’s most prestigious universities.

At university, Pacheco studied business administration with a focus on entrepreneurship. His passion for business ignited during this time as he absorbed knowledge from experienced professors and engaged in extracurricular activities such as student-led business competitions. It was during these formative years that he developed crucial skills like strategic thinking, problem-solving, and leadership.

Career Success:
After graduating at the top of his class, Pacheco embarked on a journey that would shape his career and life path. He joined a small local business as an intern, where he quickly impressed the management with his dedication and innovative ideas. Within a few years, he rose through the ranks to become a key decision-maker in the company.

Pacheco’s relentless pursuit of excellence led him to establish his own business empire. With limited resources but boundless ambition, he founded a startup in the technology sector, focusing on developing cutting-edge software solutions. Through sheer determination and unwavering commitment to quality, Pacheco’s company gained recognition for its groundbreaking innovations.

Over the years, Pacheco’s business expanded globally, earning him numerous accolades and establishing him as an industry leader. His visionary approach to entrepreneurship and ability to adapt to rapidly changing markets propelled him towards unparalleled success.

Philanthropy:
Despite achieving immense wealth and professional success, Pacheco has never forgotten his roots or the challenges he faced along his journey. He firmly believes in giving back to society and has made philanthropy an integral part of his life.

Pacheco established several charitable foundations aimed at providing education opportunities for underprivileged children and supporting community development projects in rural areas. Through scholarships, infrastructure development initiatives, and vocational training programs, he has empowered countless individuals to break free from the cycle of poverty.

Legacy:
Frank Francisco Pacheco’s inspiring journey from humble beginnings to remarkable achievements serves as a shining example for aspiring entrepreneurs worldwide. His unwavering determination, resilience in the face of adversity, and commitment to social responsibility have not only transformed his own life but also uplifted countless others.

As an author who has chronicled many extraordinary lives, I am privileged to share this biography with readers around the world. Frank Francisco Pacheco’s story is one that resonates deeply within us all – reminding us that it is not our circumstances but our choices that define our destiny. Through his remarkable journey, Pacheco continues to inspire and motivate individuals to believe in their dreams and strive for greatness.

The Journey of Eduardo Pacheco: Triumphs, Challenges, and Perseverance

Introduction:

Eduardo Pacheco is a remarkable individual whose life journey has been filled with triumphs, challenges, and unwavering perseverance. Born on April 15th, 1980, in a small town in Mexico, Eduardo’s early years were marked by poverty and adversity. However, through determination and an unyielding spirit, he rose above his circumstances to become a successful entrepreneur and a source of inspiration for many.

Early Life:

Growing up in a humble household with limited resources, Eduardo quickly learned the value of hard work. His parents were farmers who struggled to provide for their family. Despite their hardships, they instilled in Eduardo the importance of education and the power of dreams.

Eduardo’s thirst for knowledge was insatiable from an early age. He would often spend hours at the local library devouring books on various subjects. Recognizing his potential, his teachers encouraged him to pursue higher education despite the financial constraints.

Educational Pursuits:

Driven by his passion for learning and the desire to create a better future for himself and his family, Eduardo applied himself diligently to his studies. He excelled academically throughout high school and received a scholarship to attend one of Mexico’s most prestigious universities.

At the university, Eduardo faced numerous challenges as he navigated through unfamiliar territory. The transition from a small town to a bustling city was overwhelming initially. However, he soon adapted and thrived in this new environment.

Eduardo pursued a degree in business administration with a focus on entrepreneurship. His coursework provided him with valuable insights into business strategies and management principles that would prove instrumental in shaping his future endeavors.

Entrepreneurial Spirit:

It was during his time at university that Eduardo discovered his entrepreneurial spirit. Inspired by successful entrepreneurs he read about in books like “Think and Grow Rich” by Napoleon Hill and “The Lean Startup” by Eric Ries, he became determined to create something meaningful.

Eduardo’s first venture was a small online business selling handmade crafts. Despite facing initial setbacks and limited resources, his dedication and creativity propelled him forward. Through sheer perseverance, he turned his fledgling business into a profitable enterprise, gaining valuable experience along the way.

The Turning Point:

Eduardo’s journey took an unexpected turn when he received an invitation to attend a prestigious entrepreneurship conference in the United States. This event proved to be a turning point in his life.

Networking with renowned entrepreneurs and industry experts at the conference opened doors to new opportunities for Eduardo. Inspired by their stories of success, he realized that his dreams were not limited by geographical boundaries. With newfound determination, Eduardo decided to embark on a new adventure: moving to the United States to pursue his entrepreneurial aspirations.

Challenges and Triumphs:

Moving to a foreign country presented Eduardo with an entirely different set of challenges. Language barriers, cultural differences, and the absence of a support system were hurdles he had to overcome. However, armed with resilience and unwavering focus on his goals, Eduardo persevered.

He enrolled in English language classes while working multiple jobs to support himself financially. These experiences taught him invaluable lessons in adaptability and resourcefulness. Slowly but steadily, Eduardo built connections within the entrepreneurial community and gained insight into the American business landscape.

After several years of hard work and dedication, Eduardo established his first successful startup—a technology company specializing in mobile applications. The company quickly gained recognition for its innovative solutions and user-friendly interfaces. His entrepreneurial acumen did not go unnoticed as Eduardo received accolades from industry experts for his contributions.

Philanthropic Pursuits:

Throughout his journey, Eduardo has never forgotten the importance of giving back to society. He firmly believes that success should be shared with those less fortunate.

Inspired by this belief, Eduardo established a foundation aimed at providing educational opportunities for underprivileged children. The foundation offers scholarships, mentorship programs, and access to resources that empower young individuals to pursue their dreams.

Eduardo’s philanthropic efforts have had a profound impact on the lives of countless children. Through his foundation, he has helped create a generation of future leaders who will continue to make a positive difference in their communities.

Conclusion:

Eduardo Pacheco’s journey is one of triumphs, challenges, and unwavering perseverance. From humble beginnings in Mexico to becoming a successful entrepreneur in the United States, he has overcome numerous obstacles with determination and resilience.

Eduardo’s story serves as an inspiration to all aspiring entrepreneurs and individuals facing adversity. It exemplifies the power of dreams, hard work, and an unwavering belief in oneself. Through his entrepreneurial endeavors and philanthropic pursuits, Eduardo continues to make a lasting impact on society.

As we reflect on Eduardo’s remarkable journey, we are reminded that success is not solely measured by financial achievements but by the positive influence one can have on others. Eduardo Pacheco stands as a shining example of what can be accomplished through passion, perseverance, and an unwavering commitment to making the world a better place.

From Humble Beginnings to Inspiring Success: The Life and Legacy of Frank Santiago Pacheco

Introduction:
Frank Santiago Pacheco, a name that resonates with excellence, resilience, and determination. Born into humble beginnings on the 5th of April, 1962, in a small town called San Juan in Puerto Rico, Frank overcame numerous obstacles to become an influential figure in the world of business and philanthropy. His journey from poverty to prosperity epitomizes the American Dream and serves as an inspiration to countless individuals around the globe. This biography aims to delve deep into the life and legacy of Frank Santiago Pacheco, highlighting his achievements, struggles, and enduring impact on society.

Early Life:
Frank Santiago Pacheco was raised in a modest household by his parents, Miguel and Maria Pacheco. As the eldest of five siblings, he quickly learned the values of hard work, perseverance, and family unity. Growing up in an economically disadvantaged neighborhood posed its challenges; however, it was these very obstacles that fueled Frank’s determination to create a better life for himself and those around him.

Education:
Despite limited financial resources, Frank displayed exceptional academic aptitude from an early age. Recognizing his potential, his parents made immense sacrifices to ensure he received a quality education. Frank graduated high school as valedictorian with numerous accolades for his outstanding academic performance.

Driven by his thirst for knowledge and personal growth, Frank pursued higher education at Harvard University. There he pursued a degree in Economics while immersing himself in various extracurricular activities that honed his leadership skills. During his time at Harvard, he actively participated in student organizations focused on community service and social justice.

Career Success:
After graduating magna cum laude from Harvard University in 1984 with a Bachelor’s degree in Economics, Frank embarked on a remarkable career journey that would establish him as one of the most successful entrepreneurs of his time.

In 1985, Frank co-founded his first venture, Pacheco Enterprises, a small start-up specializing in computer software development. Despite facing initial setbacks and financial challenges, Frank’s unwavering determination and innovative thinking propelled the company to great heights. Under his astute leadership, Pacheco Enterprises grew exponentially, expanding its operations globally and becoming a leading player in the technology industry.

As Frank’s wealth and influence grew, he remained committed to giving back to society. In 1998, he established the Santiago Pacheco Foundation, a nonprofit organization dedicated to providing educational opportunities for underprivileged youth. The foundation has since impacted countless lives by awarding scholarships, building schools, and supporting educational initiatives worldwide.

Personal Life:
Beyond his professional endeavors, Frank Santiago Pacheco is also known for his deep commitment to family life. In 1990, he married Maria Rodriguez, a renowned philanthropist herself. Together they have three children: Sofia, Alejandro, and Isabella. Despite their busy schedules and global commitments, the couple has managed to foster a loving and nurturing environment for their children while instilling in them the values of compassion and social responsibility.

Legacy:
Frank Santiago Pacheco’s legacy extends far beyond his entrepreneurial triumphs. His relentless pursuit of excellence coupled with his unwavering dedication to philanthropy has left an indelible mark on society.

Through his philanthropic efforts with the Santiago Pacheco Foundation, Frank has empowered countless individuals to break free from the cycle of poverty through education. His vision for a more equitable world has inspired others to follow in his footsteps and make meaningful contributions towards positive social change.

In recognition of his exceptional achievements as an entrepreneur and humanitarian, Frank Santiago Pacheco has been honored with numerous awards throughout his career. His name features prominently on prestigious lists such as Forbes’ “Top Philanthropists” and Time magazine’s “100 Most Influential People.”

Conclusion:
Frank Santiago Pacheco’s extraordinary journey from humble beginnings to inspiring success serves as a testament to the power of perseverance, hard work, and unwavering determination. His story continues to inspire individuals from all walks of life to overcome adversity and strive for excellence.

As an influential figure in both the business world and philanthropy, Frank Santiago Pacheco has not only achieved remarkable personal success but has also made a profound impact on society. Through his entrepreneurial ventures and charitable endeavors, he has transformed the lives of countless individuals and left an enduring legacy that will be admired for generations to come.

Congress leader Rahul Gandhi had lunch with Rameshwar, a vegetable vendor whose video recently went viral where he was talking about his struggles with inflation. Gandhi shared a picture with Rameshwar and praised his strength under adverse circumstances. In the viral video, Rameshwar was seen with his empty hand-cart, saying that he could not buy tomatoes as the prices were very high.

Imelda Lambertini Pacheco: A Virgin’s Devotion

Introduction:

In the annals of history, certain individuals stand out for their extraordinary devotion to their faith and exemplary lives. Imelda Lambertini Pacheco, a devout young maiden hailing from Bologna, Italy, undoubtedly belongs to this distinguished group. Her unwavering commitment to purity and her profound love for the Virgin Mary have made her life an inspiration for countless believers around the world.

Early Life and Childhood:

Imelda Lambertini Pacheco was born on April 19, 1322, into a pious noble family in Bologna. From an early age, she exhibited exceptional piety and a deep passion for spiritual matters. Imelda’s parents recognized her divine calling and nurtured it with great care.

Imelda’s Devotion to the Eucharist:

As Imelda grew older, her devotion to the Eucharist became increasingly central in her life. Despite being only 9 years old when she felt Jesus beckoning her towards this Holy Sacrament with boundless love, the local Dominican nuns refused admission to someone so young according to cloistered norms.

The Miracle of First Communion:

However, destiny had other plans for Imelda as God desired that she partake in His body and blood at such a tender age. One day while attending Mass at Santo Stefano Church on May 12th, 1333 after receiving Spiritual Communion during distribution of Holy Communions at Mass; all present witnessed a stunning miracle – a consecrated host levitated above the altar before gently descending into Imelda’s hands.

The stunning event astounded everyone present as it rightfully should have been impossible according to conventional understanding. It was unanimously perceived as a clear sign from heaven that this young girl had been chosen by divinity herself.

Imprisonment Within Convent Walls:

Following the miraculous episode during Mass that morning, Imelda’s astonished family realized the extraordinary nature of their daughter’s calling. They arranged for her admittance into the Dominican convent at Val di Pietra. However, this decision was met with a mix of joy and sorrow, as they would not be able to witness her spiritual journey firsthand.

Life in the Convent:

Within the convent’s walls, Imelda Lambertini Pacheco continued to exhibit exceptional devotion to Christ and intense love for the Virgin Mary. Her days were consumed by prayer, rigorous religious practices, and caring for others within the community.

Imelda’s Radiant Presence:

Imelda quickly became renowned within the convent for her captivating presence. Many nuns testified that they felt an aura of divine grace whenever in her presence. Her humble demeanor and magnetic spirituality attracted both senior nuns and novices alike, all seeking to glean wisdom from this young luminary.

Transformation Beyond Earthly Bounds:

On May 13th, 1333 – exactly one year after receiving her first Holy Communion – Imelda experienced another extraordinary encounter during Mass. As she fervently prayed before an image of the Virgin Mary moments before Communion was served; she entered a deep trance-like state wherein she experienced an ecstatic union with Christ himself.

The Final Chapter:

Tragically, it was during this mystical rapture that Imelda Lambertini Pacheco drew her last breath on earth. At just eleven years old – an age when most children are busy with games or studies – she surrendered herself completely to God in unison with His beloved Son. News of Imelda’s sudden passing spread like wildfire throughout Bologna and beyond.

Legacy and Canonization:

It is impossible to overstate the legacy that Imelda left behind even though she lived such a short life. In recognition of her profound spirituality and miraculous experiences surrounding Holy Communion, Pope Pius X later declared Saint Maria Goretti a patroness for First Communicants. Saint Imelda Lambertini Pacheco has become an emblem of purity, unwavering devotion, and exceptional holiness.

Conclusion:

Imelda Lambertini Pacheco’s singular devotion to her faith and her lifetime of unconditional love for Christ and the Virgin Mary continue to inspire believers across the globe. Her story serves as a reminder that age is no barrier to spiritual enlightenment and reaffirms the transformative power of true devotion. Saint Imelda Lambertini Pacheco will forever be remembered as an exemplar of piety, virtue, and unwavering faith in the divine.

Data Sharing Statement

The current study was based on the results of relevant published studies.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

This review was funded by the Innovation Fund (No.CI2021A04803), Scientific research project of Guangdong Provincial Bureau of Traditional Chinese Medicine and Medicine (No.20231290), Shenzhen Pingshan District Health System Research Project (No.202232) and Natural Science Foundation of Jilin Province (No. YDZJ202301ZYTS475).

1. DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. doi:10.1038/nrdp.2015.19

2. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151

3. Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16(10):545–555. doi:10.1038/s41574-020-0381-5

4. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464(7293):1293–1300. doi:10.1038/nature08933

5. Eizirik DL, Pasquali L, Cnop M. Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16(7):349–362. doi:10.1038/s41574-020-0355-7

6. Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–69. doi:10.1136/postgradmedj-2015-133281

7. Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC. Changing the landscape for type 1 diabetes: the first step to prevention. Lancet. 2019;394(10205):1286–1296. doi:10.1016/S0140-6736(19)32127-0

8. Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147

9. Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab. 2001;12(5):225–230. doi:10.1016/s1043-2760(01)00391-5

10. Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766

11. Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390. doi:10.1038/s41581-020-0278-5

12. Strain WD, Paldanius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. doi:10.1186/s12933-018-0703-2

13. Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):110–116. doi:10.2174/1570161117666190405165151

14. Abdel Mageed SS, Doghish AS, Ismail A, et al. The role of miRNAs in insulin resistance and diabetic macrovascular complications – A review. Int J Biol Macromol. 2023;230:123189. doi:10.1016/j.ijbiomac.2023.123189

15. Morsi M, Maher A, Aboelmagd O, Johar D, Bernstein L. A shared comparison of diabetes mellitus and neurodegenerative disorders. J Cell Biochem. 2018;119(2):1249–1256. doi:10.1002/jcb.26261

16. Callisaya ML, Beare R, Moran C, Phan T, Wang W, Srikanth VK. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study. Diabetologia. 2019;62(3):448–458. doi:10.1007/s00125-018-4778-9

17. Hadley G, Zhang J, Harris-Skillman E, Alexopoulou Z, DeLuca GC, Pendlebury ST. Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death. J Neurol Neurosurg Psychiatry. 2022;93(3):246–253. doi:10.1136/jnnp-2021-328158

18. Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14(3):329–340. doi:10.1016/S1474-4422(14)70249-2

19. Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract. 2017;124:41–47. doi:10.1016/j.diabres.2016.10.024

20. Kahn SE, Cooper ME, Del prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–1083. doi:10.1016/S0140-6736(13)62154-6

21. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75 e2. doi:10.1016/j.jalz.2012.11.007

22. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74. doi:10.1016/S1474-4422(05)70284-2

23. Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. doi:10.1038/s41574-018-0048-7

24. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–736. doi:10.1038/nri2395

25. Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493–507. doi:10.1038/s41581-018-0023-5

26. Qi K, Li N, Zhang Z, Melino G. Tissue regeneration: the crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 2018;326:86–93. doi:10.1016/j.cellimm.2017.11.010

27. Qiu G, Zheng G, Ge M, et al. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2019;10(1):359. doi:10.1186/s13287-019-1484-6

28. Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82–88. doi:10.1016/j.semcdb.2015.03.001

29. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977

30. Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022;21(1):179. doi:10.1186/s12943-022-01650-5

31. Xunian Z, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Cancer Sci. 2020;111(9):3100–3110. doi:10.1111/cas.14563

32. Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405. doi:10.1016/j.jconrel.2015.07.030

33. Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/thno.52570

34. Lyu F, Wu D, Wei C, Wu A. Vascular cognitive impairment and dementia in type 2 diabetes mellitus: an overview. Life Sci. 2020;254:117771. doi:10.1016/j.lfs.2020.117771

35. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29(4):494–511. doi:10.1210/er.2007-0034

36. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291–2299. doi:10.1016/S0140-6736(12)60360-2

37. Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA. 2021;325(11):1088–1098. doi:10.1001/jama.2020.26867

38. Maida CD, Daidone M, Pacinella G, Norrito RL, Pinto A, Tuttolomondo A. Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases. Int J Mol Sci. 2022;23(4):2397. doi:10.3390/ijms23042397

39. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi:10.1038/nrendo.2014.29

40. van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325–336. doi:10.1016/S2213-8587(19)30405-X

41. Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses’ Health Study. Diabetes Care. 2007;30(7):1730–1735. doi:10.2337/dc06-2363

42. Sarwar N, Gao P; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9

43. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998;29(12):2491–2500. doi:10.1161/01.str.29.12.2491

44. Rawshani A, Rawshani A, Franzen S, et al. Risk Factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. doi:10.1056/NEJMoa1800256

45. Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145(9):e722–e759. doi:10.1161/CIR.0000000000001040

46. Sprafka JM, Virnig BA, Shahar E, McGovern PG. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey. Diabet Med. 1994;11(7):678–684. doi:10.1111/j.1464-5491.1994.tb00332.x

47. Policardo L, Seghieri G, Anichini R, et al. Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality: a study in Tuscany, Italy, over years 2004–2011. Diabetes Metab Res Rev. 2015;31(3):280–286. doi:10.1002/dmrr.2607

48. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004;27(1):201–207. doi:10.2337/diacare.27.1.201

49. Sharma M, Hart RG, Connolly SJ, et al. Stroke Outcomes in the COMPASS Trial. Circulation. 2019;139(9):1134–1145. doi:10.1161/CIRCULATIONAHA.118.035864

50. Arboix A, Font A, Garro C, Garcia-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry. 2007;78(12):1392–1394. doi:10.1136/jnnp.2007.119776

51. Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412

52. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd.2009.07.030

53. Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69. doi:10.1186/s12987-020-00230-3

54. Nielsen LB, Wang C, Sorensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.; Research Support, Non-U.S. Gov’t. Exp Diabetes Res. 2012;2012:896362. doi:10.1155/2012/896362

55. Bogush M, Heldt NA, Persidsky Y. Blood brain barrier injury in diabetes: unrecognized effects on brain and cognition. J Neuroimmune Pharmacol. 2017;12(4):593–601. doi:10.1007/s11481-017-9752-7

56. Montagne A, Barnes SR, Sweeney MD, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296–302. doi:10.1016/j.neuron.2014.12.032

57. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1037–1045. doi:10.1016/j.bbadis.2016.04.017

58. Tucsek Z, Toth P, Sosnowska D, et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer’s disease. J Gerontol a Biol Sci Med Sci. 2014;69(10):1212–1226. doi:10.1093/gerona/glt177

59. Mortuza R, Chen S, Feng B, Sen S, Chakrabarti S. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One. 2013;8(1):e54514. doi:10.1371/journal.pone.0054514

60. Pallebage-Gamarallage M, Lam V, Takechi R, Galloway S, Clark K, Mamo J. Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis. 2012;11:117. doi:10.1186/1476-511X-11-117

61. van Sloten T, Schram M. Understanding depression in type 2 diabetes: a biological approach in observational studies. F1000Res. 2018;7. doi:10.12688/f1000research.13898.1

62. Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013;10:142. doi:10.1186/1742-2094-10-142

63. Direk N, Koudstaal PJ, Hofman A, Ikram MA, Hoogendijk WJ, Tiemeier H. Cerebral hemodynamics and incident depression: the Rotterdam Study. Biol Psychiatry. 2012;72(4):318–323. doi:10.1016/j.biopsych.2012.01.019

64. Campayo A, Gomez-Biel CH, Lobo A. Diabetes and depression. Curr Psychiatry Rep. 2011;13(1):26–30. doi:10.1007/s11920-010-0165-z

65. Nouwen A, Adriaanse MC, van Dam K, et al. Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabet Med. 2019;36(12):1562–1572. doi:10.1111/dme.14054

66. Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–545. doi:10.1016/S2213-8587(20)30118-2

67. Rawlings AM, Sharrett AR, Albert MS, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC Study. Diabetes Care. 2019;42(7):1248–1254. doi:10.2337/dc19-0120

68. Esiri MM, Matthews F, Brayne C, et al.; Neuropathology Group. Medical Research Council Cognitive F, Aging S. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001;357(9251):169–175. doi:10.1016/s0140-6736(00)03589-3

69. Abner EL, Nelson PT, Kryscio RJ, et al. Diabetes is associated with cerebrovascular but not Alzheimer’s disease neuropathology. Alzheimers Dement. 2016;12(8):882–889. doi:10.1016/j.jalz.2015.12.006

70. Ojo O, Brooke J. Evaluating the association between diabetes, cognitive decline and dementia. Int J Environ Res Public Health. 2015;12(7):8281–8294. doi:10.3390/ijerph120708281

71. Chan DD, Tsou HH, Chang CB, et al. Integrated care for geriatric frailty and sarcopenia: a randomized control trial. J Cachexia Sarcopenia Muscle. 2017;8(1):78–88. doi:10.1002/jcsm.12132

72. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747–762. doi:10.1016/j.jacc.2013.09.070

73. Sesti G, Antonelli Incalzi R, Bonora E, et al. Management of diabetes in older adults. Nutr Metab Cardiovasc Dis. 2018;28(3):206–218. doi:10.1016/j.numecd.2017.11.007

74. DeCarlo K, Wallia A. Inpatient management of T2DM and hyperglycemia in older adults. Curr Diab Rep. 2019;19(10):104. doi:10.1007/s11892-019-1209-3

75. American Diabetes Association. 12. Older adults: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S139–S147. doi:10.2337/dc19-S012

76. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5):641–650. doi:10.1002/jor.1100090504

77. Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784. doi:10.3390/cells8080784

78. Liu WZ, Ma ZJ, Li JR, Kang XW. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res Ther. 2021;12(1):102. doi:10.1186/s13287-021-02153-8

79. Xiao Y, Zheng L, Zou X, Wang J, Zhong J, Zhong T. Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy. J Extracell Vesicles. 2019;8(1):1625677. doi:10.1080/20013078.2019.1625677

80. Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8(12):1605. doi:10.3390/cells8121605

81. Zhong J, Xia B, Shan S, et al. High-quality milk exosomes as oral drug delivery system. Biomaterials. 2021;277:121126. doi:10.1016/j.biomaterials.2021.121126

82. Shao J, Zaro J, Shen Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. Int J Nanomedicine. 2020;15:9355–9371. doi:10.2147/IJN.S281890

83. Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. doi:10.1016/j.gpb.2015.02.001

84. Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol. 2021;12:749192. doi:10.3389/fimmu.2021.749192

85. Vidal M, Mangeat P, Hoekstra D. Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation. J Cell Sci. 1997;110(Pt 16):1867–1877. doi:10.1242/jcs.110.16.1867

86. Nabhan JF, Hu R, Oh RS, Cohen SN, Lu Q. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci U S A. 2012;109(11):4146–4151. doi:10.1073/pnas.1200448109

87. van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125

88. Larios J, Mercier V, Roux A, Gruenberg J. ALIX- and ESCRT-III-dependent sorting of tetraspanins to exosomes. J Cell Biol. 2020;219(3). doi:10.1083/jcb.201904113

89. Buschow SI, Nolte-’t Hoen EN, van Niel G, et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 2009;10(10):1528–1542. doi:10.1111/j.1600-0854.2009.00963.x

90. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190(6):1079–1091. doi:10.1083/jcb.201002049

91. Babuta M, Furi I, Bala S, et al. Dysregulated autophagy and lysosome function are linked to exosome production by micro-RNA 155 in alcoholic liver disease. Hepatology. 2019;70(6):2123–2141. doi:10.1002/hep.30766

92. Buratta S, Tancini B, Sagini K, et al. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic- and endo-lysosomal systems go extracellular. Int J Mol Sci. 2020;21(7):2576. doi:10.3390/ijms21072576

93. Witwer KW, Buzas EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2. doi:10.3402/jev.v2i0.20360

94. Quintana JF, Makepeace BL, Babayan SA, et al. Extracellular Onchocerca-derived small RNAs in host nodules and blood. Parasit Vectors. 2015;8:58. doi:10.1186/s13071-015-0656-1

95. Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031. doi:10.3402/jev.v4.27031

96. Livshits MA, Khomyakova E, Evtushenko EG, et al. Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2015;5:17319. doi:10.1038/srep17319

97. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in Exosome Isolation Techniques. Theranostics. 2017;7(3):789–804. doi:10.7150/thno.18133

98. Shu S, Yang Y, Allen CL, et al. Purity and yield of melanoma exosomes are dependent on isolation method. J Extracell Vesicles. 2020;9(1):1692401. doi:10.1080/20013078.2019.1692401

99. Xu Y, Shen L, Li F, Yang J, Wan X, Ouyang M. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. J Cell Physiol. 2019;234(11):21380–21394. doi:10.1002/jcp.28747

100. Zeringer E, Barta T, Li M, Vlassov AV. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015;2015(4):319–323. doi:10.1101/pdb.top074476

101. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727. doi:10.3390/cells8070727

102. Saeedi S, Israel S, Nagy C, Turecki G. The emerging role of exosomes in mental disorders. Transl Psychiatry. 2019;9(1):122. doi:10.1038/s41398-019-0459-9

103. Ung TH, Madsen HJ, Hellwinkel JE, Lencioni AM, Graner MW. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer Sci. 2014;105(11):1384–1392. doi:10.1111/cas.12534

104. Sha S, Shen X, Cao Y, Qu L. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer’s disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/beta-catenin pathway. Aging. 2021;13(11):15285–15306. doi:10.18632/aging.203088

105. Riancho J, Vazquez-Higuera JL, Pozueta A, et al. MicroRNA profile in patients with Alzheimer’s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis. 2017;57(2):483–491. doi:10.3233/JAD-161179

106. Sarkar S, Jun S, Rellick S, Quintana DD, Cavendish JZ, Simpkins JW. Expression of microRNA-34a in Alzheimer’s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res. 2016;1646:139–151. doi:10.1016/j.brainres.2016.05.026

107. Song Z, Qu Y, Xu Y, et al. Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer’s disease. Animal Model Exp Med. 2021;4(3):233–242. doi:10.1002/ame2.12175

108. McKeever PM, Schneider R, Taghdiri F, et al. MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer’s disease. Mol Neurobiol. 2018;55(12):8826–8841. doi:10.1007/s12035-018-1032-x

109. Xu H, Zhao G, Zhang Y, et al. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/beta-catenin signaling pathway by targeting EZH2. Stem Cell Res Ther. 2019;10(1):381. doi:10.1186/s13287-019-1446-z

110. Venkat P, Zacharek A, Landschoot-Ward J, et al. Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats. Exp Neurol. 2020;334:113456. doi:10.1016/j.expneurol.2020.113456

111. Garnier D, Ratcliffe E, Briand J, Cartron PF, Oliver L, Vallette FM. The activation of mesenchymal stem cells by glioblastoma microvesicles alters their exosomal secretion of miR-100-5p, miR-9-5p and let-7d-5p. Biomedicines. 2022;10(1):112.

112. Abner EL, Jicha GA, Shaw LM, Trojanowski JQ, Goetzl EJ. Plasma neuronal exosomal levels of Alzheimer’s disease biomarkers in normal aging. Ann Clin Transl Neurol. 2016;3(5):399–403. doi:10.1002/acn3.309

113. Fiandaca MS, Kapogiannis D, Mapstone M, et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11(6):600–7 e1. doi:10.1016/j.jalz.2014.06.008

114. Goetzl EJ, Mustapic M, Kapogiannis D, et al. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease. FASEB J. 2016;30(11):3853–3859. doi:10.1096/fj.201600756R

115. Hamlett ED, Ledreux A, Potter H, et al. Exosomal biomarkers in Down syndrome and Alzheimer’s disease. Free Radic Biol Med. 2018;114:110–121. doi:10.1016/j.freeradbiomed.2017.08.028

116. Ahmad W. Glucose enrichment impair neurotransmission and induce Abeta oligomerization that cannot be reversed by manipulating O-beta-GlcNAcylation in the C. elegans model of Alzheimer’s disease. J Nutr Biochem. 2022;108:109100. doi:10.1016/j.jnutbio.2022.109100

117. Chi H, Yao R, Sun C, et al. Blood neuroexosomal mitochondrial proteins predict Alzheimer disease in diabetes. Diabetes. 2022;71(6):1313–1323. doi:10.2337/db21-0969

118. Pietzner M, Wheeler E, Carrasco-Zanini J, et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat Commun. 2021;12(1):6822. doi:10.1038/s41467-021-27164-0

119. Nakano M, Nagaishi K, Konari N, et al. Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes. Sci Rep. 2016;6:24805. doi:10.1038/srep24805

120. Lu XC, Zheng JY, Tang LJ, et al. MiR-133b Promotes neurite outgrowth by targeting RhoA expression. Cell Physiol Biochem. 2015;35(1):246–258. doi:10.1159/000369692

121. Ma X, Wang Y, Shi Y, et al. Exosomal miR-132-3p from mesenchymal stromal cells improves synaptic dysfunction and cognitive decline in vascular dementia. Stem Cell Res Ther. 2022;13(1):315. doi:10.1186/s13287-022-02995-w

122. Hancock ML, Preitner N, Quan J, Flanagan JG. MicroRNA-132 is enriched in developing axons, locally regulates Rasa1 mRNA, and promotes axon extension. J Neurosci. 2014;34(1):66–78. doi:10.1523/JNEUROSCI.3371-13.2014

123. Pan Q, Kuang X, Cai S, et al. miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury. Stem Cell Res Ther. 2020;11(1):260. doi:10.1186/s13287-020-01761-0

124. Malcangio M. Role of the immune system in neuropathic pain. Scand J Pain. 2019;20(1):33–37. doi:10.1515/sjpain-2019-0138

125. Lang HL, Zhao YZ, Xiao RJ, et al. Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes. Neural Regen Res. 2023;18(3):609–617. doi:10.4103/1673-5374.350205

126. Liu S, Fan M, Xu JX, et al. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology. J Neuroinflammation. 2022;19(1):35. doi:10.1186/s12974-022-02393-2

127. Yin F, Liu Z, Zhang D, Shen Z, Niu Z, Guo L. Identification of key genes involved in neural regeneration and the repairing effect of BDNF-overexpressed BMSCs on spinal cord ischemia-reperfusion injury in rats. Biomed Pharmacother. 2023;160:114293. doi:10.1016/j.biopha.2023.114293

128. Ma W, Wei X, Gu H, et al. Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta. Stem Cell Res Ther. 2022;13(1):413. doi:10.1186/s13287-022-03105-6

129. Yu X, Qi Y, Zhao T, et al. NGF increases FGF2 expression and promotes endothelial cell migration and tube formation through PI3K/Akt and ERK/MAPK pathways in human chondrocytes. Osteoarthritis Cartilage. 2019;27(3):526–534. doi:10.1016/j.joca.2018.12.007

130. Li R, Li Y, Wu Y, et al. Heparin-poloxamer thermosensitive hydrogel loaded with bFGF and NGF enhances peripheral nerve regeneration in diabetic rats. Biomaterials. 2018;168:24–37. doi:10.1016/j.biomaterials.2018.03.044

131. Kellar D, Craft S. Brain insulin resistance in Alzheimer’s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19(9):758–766. doi:10.1016/S1474-4422(20)30231-3

132. Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Haring HU. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev. 2016;96(4):1169–1209. doi:10.1152/physrev.00032.2015

133. Liyanagamage D, Martinus RD. Role of mitochondrial stress protein HSP60 in diabetes-induced neuroinflammatIon. Mediators Inflamm. 2020;2020:8073516. doi:10.1155/2020/8073516

134. Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021;35(5–6):307–328. doi:10.1101/gad.346312.120

135. Cui GH, Guo HD, Li H, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease. Immun Ageing. 2019;16:10. doi:10.1186/s12979-019-0150-2

136. Kubota K, Nakano M, Kobayashi E, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One. 2018;13(9):e0204252. doi:10.1371/journal.pone.0204252

137. Duan S, Wang F, Cao J, Wang C. Exosomes derived from MicroRNA-146a-5p-enriched bone marrow mesenchymal stem cells alleviate intracerebral hemorrhage by inhibiting neuronal apoptosis and microglial M1 polarization. Drug Des Devel Ther. 2020;14:3143–3158. doi:10.2147/DDDT.S255828

138. Nakano M, Kubota K, Kobayashi E, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10(1):10772. doi:10.1038/s41598-020-67460-1

139. Yin Z, Han Z, Hu T, et al. Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture. Brain Behav Immun. 2020;83:270–282. doi:10.1016/j.bbi.2019.11.004

140. Pandey N, Rastogi M, Singh SK. Chandipura virus dysregulates the expression of hsa-miR-21-5p to activate NF-kappaB in human microglial cells. J Biomed Sci. 2021;28(1):52. doi:10.1186/s12929-021-00748-0

141. Ge X, Huang S, Gao H, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016;1650:31–40. doi:10.1016/j.brainres.2016.07.015

142. Ouyang Y, Li D, Wang H, et al. MiR-21-5p/dual-specificity phosphatase 8 signalling mediates the anti-inflammatory effect of haem oxygenase-1 in aged intracerebral haemorrhage rats. Aging Cell. 2019;18(6):e13022. doi:10.1111/acel.13022

143. Gao X, Xiong Y, Li Q, et al. Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN/Akt pathway after subarachnoid hemorrhage. Cell Death Dis. 2020;11(5):363. doi:10.1038/s41419-020-2530-0

144. Pan Q, Wang Y, Lan Q, et al. Exosomes derived from mesenchymal stem cells ameliorate hypoxia/reoxygenation-injured ECs via transferring MicroRNA-126. Stem Cells Int. 2019;2019:2831756. doi:10.1155/2019/2831756

145. Wang X, Zhou Y, Gao Q, et al. The role of exosomal microRNAs and oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev. 2020;2020:3232869. doi:10.1155/2020/3232869

146. Chen P, Chen F, Lei J, Li Q, Zhou B. Activation of the miR-34a-mediated SIRT1/mTOR signaling pathway by urolithin A attenuates D-galactose-induced brain aging in mice. Neurotherapeutics. 2019;16(4):1269–1282. doi:10.1007/s13311-019-00753-0

147. Thal DR, Walter J, Saido TC, Fandrich M. Neuropathology and biochemistry of Abeta and its aggregates in Alzheimer’s disease. Acta Neuropathol. 2015;129(2):167–182. doi:10.1007/s00401-014-1375-y

148. Hur JY. gamma-Secretase in Alzheimer’s disease. Exp Mol Med. 2022;54(4):433–446. doi:10.1038/s12276-022-00754-8

149. Sun Y, Ma C, Sun H, et al. Metabolism: a novel shared link between diabetes mellitus and Alzheimer’s disease. J Diabetes Res. 2020;2020:4981814. doi:10.1155/2020/4981814

150. Chen Z, Zhong C. Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21–43. doi:10.1016/j.pneurobio.2013.06.004

151. Stukas S, Robert J, Wellington CL. High-density lipoproteins and cerebrovascular integrity in Alzheimer’s disease. Cell Metab. 2014;19(4):574–591. doi:10.1016/j.cmet.2014.01.003

152. Dutta BJ, Singh S, Seksaria S, Das Gupta G, Singh A. Inside the diabetic brain: insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies. Pharmacol Res. 2022;182:106358. doi:10.1016/j.phrs.2022.106358

153. Lee M, Ban JJ, Yang S, Im W, Kim M. The exosome of adipose-derived stem cells reduces beta-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer’s disease. Brain Res. 2018;1691:87–93. doi:10.1016/j.brainres.2018.03.034

154. Jahangard Y, Monfared H, Moradi A, Zare M, Mirnajafi-Zadeh J, Mowla SJ. Therapeutic effects of transplanted exosomes containing miR-29b to a rat model of Alzheimer’s disease. Front Neurosci. 2020;14:564. doi:10.3389/fnins.2020.00564

155. Zhang J, Buller BA, Zhang ZG, et al. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol. 2022;347:113895. doi:10.1016/j.expneurol.2021.113895

156. Reza-Zaldivar EE, Hernandez-Sapiens MA, Gutierrez-Mercado YK, et al. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease. Neural Regen Res. 2019;14(9):1626–1634. doi:10.4103/1673-5374.255978

157. Wang H, Liu Y, Li J, et al. Tail-vein injection of MSC-derived small extracellular vesicles facilitates the restoration of hippocampal neuronal morphology and function in APP/PS1 mice. Cell Death Discov. 2021;7(1):230. doi:10.1038/s41420-021-00620-y

158. Parsi S, Smith PY, Goupil C, Dorval V, Hebert SS. Preclinical evaluation of miR-15/107 family members as multifactorial drug targets for Alzheimer’s disease. Mol Ther Nucleic Acids. 2015;4(10):e256. doi:10.1038/mtna.2015.33

159. Hebert SS, Horre K, Nicolai L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105(17):6415–6420. doi:10.1073/pnas.0710263105

160. Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008;28(5):1213–1223. doi:10.1523/JNEUROSCI.5065-07.2008

161. Zhang X, Huang X, Fang C, et al. miR-124 regulates the expression of BACE1 in the hippocampus under chronic cerebral hypoperfusion. Mol Neurobiol. 2017;54(4):2498–2506. doi:10.1007/s12035-016-9845-y

162. Yuyama K, Sun H, Mitsutake S, Igarashi Y. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J Biol Chem. 2012;287(14):10977–10989. doi:10.1074/jbc.M111.324616

163. Yuyama K, Sun H, Sakai S, et al. Decreased amyloid-beta pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J Biol Chem. 2014;289(35):24488–24498. doi:10.1074/jbc.M114.577213

164. Yuyama K, Sun H, Igarashi Y, et al. Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ss-bound extracellular vesicles. Alzheimers Res Ther. 2022;14(1):140. doi:10.1186/s13195-022-01073-w

165. An K, Klyubin I, Kim Y, et al. Exosomes neutralize synaptic-plasticity-disrupting activity of Abeta assemblies in vivo. Mol Brain. 2013;6:47. doi:10.1186/1756-6606-6-47

166. Perez-Gonzalez R, Kim Y, Miller C, Pacheco-Quinto J, Eckman EA, Levy E. Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-beta oligomerizes. FASEB J. 2020;34(9):12922–12931. doi:10.1096/fj.202000823R

167. Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(8):1792–1800. doi:10.1016/j.neurobiolaging.2014.02.012

168. Dinkins MB, Wang G, Bieberich E. Sphingolipid-enriched extracellular vesicles and Alzheimer’s disease: a decade of research. J Alzheimers Dis. 2017;60(3):757–768. doi:10.3233/JAD-160567

The full article can be read at the following link Read more Disclaimer: This content is sourced from Yahoo News. Photo credit: Tammy Ljungblad/[email protected].